![Thomas Salzmann](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dr. Salzmann sits on the Board and SAB of Satori Pharmaceuticals, a PureTech portfolio company.
Previously he was Executive Vice President, Merck Research Labs.
Dr. Salzmann's career at Merck spanned nearly 30 years in which he has also held positions including EVP Worldwide Preclinical Development, Global Operations, and Project Management and SVP Basic Research and Chemistry.
He is also a member of the MRL Executive Committee.
| Companies | Position | End |
|---|---|---|
Puretech Health LLC
 Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Private Equity Investor | 2008-07-29 |
Satori Pharmaceuticals, Inc.
 Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease | Director/Board Member | - |
| MERCK & CO., INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
| Private companies | 3 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Satori Pharmaceuticals, Inc.
Satori Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for alzheimer's disease | Health Technology |
Puretech Health LLC
Puretech Health LLC Investment ManagersFinance PureTech Ventures invests in companies located in the United States. The firm focuses on a broad range of sectors. It provides financing for seed, early and later stage capital requirements. | Finance |
Select your edition
All financial news and data tailored to specific country editions
